Recent Study: The Hepatitis C Market Forecast to 2022
Datamonitor uses a patient-based approach utilizing epidemiology data, and primary research in physicians, to estimate the size of hepatitis C sales across the US, Japan, and five major EU markets. The sales trends of key marketed and pipeline brands and the anticipated shift in the treatment paradigm are assessed from 2013-2022.
View full press release